Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device GMP violation rate continues downward trend, dropping to 20% in FY 1995.

This article was originally published in The Gray Sheet

Executive Summary

DEVICE GMP INSPECTION VIOLATION RATE DROPS TO 20% IN FY 1995, Marge Hoban, chief of the Field Programs Branch within FDA Center for Devices and Radiological Health's Office of Compliance, reported May 7 at a Regulatory Affairs Professionals Society meeting in Rockville, Maryland. Of 1,662 GMP inspections conducted by FDA in fiscal year 1995, 20% (340) were found to be violative, continuing a three-year decline in the percentage of violative GMP inspections. In FY 1994, 23% of the 1,942 GMP inspections found violations, compared to 24% of inspections in FY 1993 and 26% in FY 1992.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel